About Scott Lipman
Scott Lipman is an executive officer at Avenzo Therapeutics.
Scott Lipman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Scott Lipman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Scott Lipman works with at each company, as listed on that company's latest Form D.
Avenzo Therapeutics, Inc. · Form D, Sep 5, 2025
CG
Carl Gordon
Director
GN
Garry Nicholson
Director
PM
Patrick Machado
Director
JL
Judith Li
Director
PT
Paolo Tombesi
Executive officer
MH
Mohammad Hirmand
Executive officer
SG
Simeon George
Director
AC
Athena Countouriotis
Executive officer and director
BS
Brian Sun
Executive officer
JA
Jakob Dupont, M.D., M.A.
Director